{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:36:07Z","timestamp":1792888567038,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011930","name":"Beijing Medical and Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011930","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82571274"],"award-info":[{"award-number":["82571274"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bcp.2026.118028","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T14:55:36Z","timestamp":1777647336000},"page":"118028","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["Divergent mechanisms, unified therapy: saracatinib targets Src\/HIF signaling in endothelial and microglial cells to treat retinopathy"],"prefix":"10.1016","volume":"250","author":[{"given":"Hu","family":"Qiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luo","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Yiming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Hongsong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Jiajing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Wenyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Hafezi-Moghadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun","family":"Dawei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118028_b0005","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1742-2094-8-120","article-title":"Activation of retinal microglia rather than microglial cell density correlates with retinal neovascularization in the mouse model of oxygen-induced retinopathy","volume":"8","author":"Fischer","year":"2011","journal-title":"J. Neuroinflammation"},{"issue":"9","key":"10.1016\/j.bcp.2026.118028_b0010","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1002\/glia.24218","article-title":"Deletion of Tgfbeta signal in activated microglia prolongs hypoxia-induced retinal neovascularization enhancing Igf1 expression and retinal leukostasis","volume":"70","author":"Usui-Ouchi","year":"2022","journal-title":"Glia"},{"issue":"5","key":"10.1016\/j.bcp.2026.118028_b0015","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1007\/s40123-023-00744-7","article-title":"Laser versus Anti-VEGF: a Paradigm Shift for Treatment-Warranted Retinopathy of Prematurity","volume":"12","author":"Hartnett","year":"2023","journal-title":"Ophthalmol Ther"},{"issue":"3","key":"10.1016\/j.bcp.2026.118028_b0020","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s10792-022-02480-6","article-title":"Comparison of adverse events between intravitreal anti-VEGF and laser photocoagulation for treatment-requiring retinopathy of prematurity: a systematic review","volume":"43","author":"Tsiropoulos","year":"2023","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.bcp.2026.118028_b0025","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.preteyeres.2012.08.004","article-title":"Role of the retinal vascular endothelial cell in ocular disease","volume":"32","author":"Bharadwaj","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"issue":"4","key":"10.1016\/j.bcp.2026.118028_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19041264","article-title":"Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2","volume":"19","author":"Peach","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.bcp.2026.118028_b0035","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1080\/02713680802450976","article-title":"Glucose and TGFbeta2 modulate the viability of cultured human retinal pericytes and their VEGF release","volume":"33","author":"Vidro","year":"2008","journal-title":"Curr. Eye Res."},{"issue":"3","key":"10.1016\/j.bcp.2026.118028_b0040","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.bcmd.2006.12.003","article-title":"Vascular endothelial growth factor family of ligands and receptors: review","volume":"38","author":"Otrock","year":"2007","journal-title":"Blood Cells Mol. Dis."},{"issue":"12","key":"10.1016\/j.bcp.2026.118028_b0045","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1182\/blood-2010-12-327015","article-title":"Notch1 controls macrophage recruitment and Notch signaling is activated at sites of endothelial cell anastomosis during retinal angiogenesis in mice","volume":"118","author":"Outtz","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bcp.2026.118028_b0050","doi-asserted-by":"crossref","first-page":"9798","DOI":"10.1038\/s41598-019-46308-3","article-title":"Retinal myeloid cells regulate tip cell selection and vascular branching morphogenesis via Notch ligand Delta-like 1","volume":"9","author":"Haupt","year":"2019","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.bcp.2026.118028_b0055","doi-asserted-by":"crossref","first-page":"9087","DOI":"10.1002\/jcp.26805","article-title":"The role of hypoxia-inducible factor-2 alpha in angiogenesis","volume":"233","author":"Befani","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118028_b0060","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00018-025-05642-8","article-title":"Targeting HIF-2alpha in glioblastoma reshapes the immune infiltrate and enhances response to immune checkpoint blockade","volume":"82","author":"Espinoza","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"issue":"41","key":"10.1016\/j.bcp.2026.118028_b0065","doi-asserted-by":"crossref","first-page":"12711","DOI":"10.1073\/pnas.1501597112","article-title":"Connectivity Map-based discovery of parbendazole reveals targetable human osteogenic pathway","volume":"112","author":"Brum","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2026.118028_b0070","article-title":"Discovery and preclinical validation of drug indications using compendia of public gene expression data","volume":"3(96):96ra77","author":"Sirota","year":"2011","journal-title":"Sci. Transl. Med."},{"issue":"19","key":"10.1016\/j.bcp.2026.118028_b0075","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.1158\/1078-0432.CCR-10-0748","article-title":"Phase I safety, pharmacokinetics, and inhibition of SRC activity study of saracatinib in patients with solid tumors","volume":"16","author":"Baselga","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"49","key":"10.1016\/j.bcp.2026.118028_b0080","doi-asserted-by":"crossref","first-page":"6365","DOI":"10.1038\/onc.2008.250","article-title":"Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530","volume":"27","author":"Chang","year":"2008","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bcp.2026.118028_b0085","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41419-024-06514-y","article-title":"Saracatinib inhibits necroptosis and ameliorates psoriatic inflammation by targeting MLKL","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.bcp.2026.118028_b0090","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1158\/1535-7163.MCT-11-1020","article-title":"Antitumor activity of Src inhibitor saracatinib (AZD-0530) in preclinical models of biliary tract carcinomas","volume":"11","author":"Cavalloni","year":"2012","journal-title":"Mol. Cancer Ther."},{"issue":"12","key":"10.1016\/j.bcp.2026.118028_b0095","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/j.ajpath.2024.09.003","article-title":"Endothelial c-Src Mediates Neovascular Tuft Formation in Oxygen-Induced Retinopathy","volume":"194","author":"Frampton","year":"2024","journal-title":"Am. J. Pathol."},{"issue":"17","key":"10.1016\/j.bcp.2026.118028_b0100","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202502138R","article-title":"Dual Pro-Angiogenic and Pro-Fibrotic MARCO(+) Microglial Phenotype in Diabetic Retinopathy","volume":"39","author":"Gu","year":"2025","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.bcp.2026.118028_b0105","doi-asserted-by":"crossref","DOI":"10.1096\/fj.201903105R","article-title":"Normal vitreous promotes angiogenesis via activation of Axl","volume":"35","author":"Wu","year":"2021","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.bcp.2026.118028_b0110","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201810154","article-title":"Inhibition of Sema4D\/PlexinB1 signaling alleviates vascular dysfunction in diabetic retinopathy","volume":"12","author":"Wu","year":"2020","journal-title":"EMBO Mol. Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.118028_b0115","first-page":"101","article-title":"Oxygen-induced retinopathy in the mouse","volume":"35","author":"Smith","year":"1994","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.bcp.2026.118028_b0120","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.exer.2011.08.010","article-title":"A micro-advancer device for vitreal injection and retinal recording and stimulation","volume":"93","author":"Hultman","year":"2011","journal-title":"Exp. Eye Res."},{"issue":"10","key":"10.1016\/j.bcp.2026.118028_b0125","article-title":"Distinguished Functions of Microglia in the two Stages of Oxygen-Induced Retinopathy: a Novel Target in the Treatment of Ischemic Retinopathy","volume":"12","author":"Zhou","year":"2022","journal-title":"Life (basel)"},{"key":"10.1016\/j.bcp.2026.118028_b0130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2147\/EB.S94447","article-title":"Revisiting the mouse model of oxygen-induced retinopathy","volume":"8","author":"Kim","year":"2016","journal-title":"Eye Brain"},{"issue":"3","key":"10.1016\/j.bcp.2026.118028_b0135","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF02482605","article-title":"The mouse model of oxygen-induced retinopathy: a suitable animal model for angiogenesis research","volume":"74","author":"Gole","year":"1990","journal-title":"Doc. Ophthalmol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118028_b0140","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10633-009-9193-6","article-title":"The significance of neuronal and glial cell changes in the rat retina during oxygen-induced retinopathy","volume":"120","author":"Fletcher","year":"2010","journal-title":"Doc. Ophthalmol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118028_b0145","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00441-018-2847-5","article-title":"Microglial density determines the appearance of pathological neovascular tufts in oxygen-induced retinopathy","volume":"374","author":"Xu","year":"2018","journal-title":"Cell Tissue Res."},{"issue":"10","key":"10.1016\/j.bcp.2026.118028_b0150","doi-asserted-by":"crossref","first-page":"6968","DOI":"10.1167\/iovs.13-12126","article-title":"In vivo retinal vascular oxygen tension imaging and fluorescein angiography in the mouse model of oxygen-induced retinopathy","volume":"54","author":"Mezu-Ndubuisi","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118028_b0155","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12974-025-03345-2","article-title":"Human breast milk-derived exosomes attenuate lipopolysaccharide-induced activation in microglia","volume":"22","author":"Akinduro","year":"2025","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.bcp.2026.118028_b0160","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1172\/JCI26316","article-title":"Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A","volume":"116","author":"Nozaki","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2026.118028_b0165","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.64944","article-title":"eNOS-induced vascular barrier disruption in retinopathy by c-Src activation and tyrosine phosphorylation of VE-cadherin","volume":"10","author":"Ninchoji","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.bcp.2026.118028_b0170","first-page":"823","article-title":"Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization","volume":"23","author":"Seo","year":"2017","journal-title":"Mol. Vis."},{"issue":"1","key":"10.1016\/j.bcp.2026.118028_b0175","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s12967-025-06320-w","article-title":"Single-cell analysis identifies MKI67(+) microglia as drivers of neovascularization in proliferative diabetic retinopathy","volume":"23","author":"Zou","year":"2025","journal-title":"J. Transl. Med."},{"issue":"23","key":"10.1016\/j.bcp.2026.118028_b0180","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.160940","article-title":"Single-cell transcriptome analyses reveal microglia types associated with proliferative retinopathy","volume":"7","author":"Liu","year":"2022","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.bcp.2026.118028_b0185","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/glia.22767","article-title":"c-Src function is necessary and sufficient for triggering microglial cell activation","volume":"63","author":"Socodato","year":"2015","journal-title":"Glia"},{"issue":"24","key":"10.1016\/j.bcp.2026.118028_b0190","doi-asserted-by":"crossref","first-page":"7760","DOI":"10.1111\/febs.16197","article-title":"Src family kinases (SFKs): critical regulators of microglial homeostatic functions and neurodegeneration in Parkinson's and Alzheimer's diseases","volume":"289","author":"Portugal","year":"2022","journal-title":"FEBS J."},{"issue":"3","key":"10.1016\/j.bcp.2026.118028_b0195","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1167\/iovs.10-5798","article-title":"The roles of vitreal macrophages and circulating leukocytes in retinal neovascularization","volume":"52","author":"Kataoka","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2026.118028_b0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011103","article-title":"HIF-1alpha and HIF-2alpha are differentially activated in distinct cell populations in retinal ischaemia","volume":"5","author":"Mowat","year":"2010","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.bcp.2026.118028_b0205","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.exer.2009.06.013","article-title":"Modulating the hypoxia-inducible factor signaling pathway as a therapeutic modality to regulate retinal angiogenesis","volume":"89","author":"DeNiro","year":"2009","journal-title":"Exp. Eye Res."},{"issue":"6","key":"10.1016\/j.bcp.2026.118028_b0210","first-page":"2007","article-title":"Contrasting effect of estrogen on VEGF induction under different oxygen status and its role in murine ROP","volume":"43","author":"Miyamoto","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"50","key":"10.1016\/j.bcp.2026.118028_b0215","doi-asserted-by":"crossref","first-page":"19898","DOI":"10.1073\/pnas.0805817105","article-title":"Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy","volume":"105","author":"Sears","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.bcp.2026.118028_b0220","doi-asserted-by":"crossref","DOI":"10.1172\/JCI139202","article-title":"HIF-1alpha and HIF-2alpha redundantly promote retinal neovascularization in patients with ischemic retinal disease","volume":"131","author":"Zhang","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.bcp.2026.118028_b0225","doi-asserted-by":"crossref","first-page":"C847","DOI":"10.1152\/ajpcell.00418.2009","article-title":"Role of FAK phosphorylation in hypoxia-induced hMSCS migration: involvement of VEGF as well as MAPKS and eNOS pathways","volume":"298","author":"Lee","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"5","key":"10.1016\/j.bcp.2026.118028_b0230","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/carcin\/bgr034","article-title":"Src activates HIF-1alpha not through direct phosphorylation of HIF-1alpha specific prolyl-4 hydroxylase 2 but through activation of the NADPH oxidase\/Rac pathway","volume":"32","author":"Lee","year":"2011","journal-title":"Carcinogenesis"},{"issue":"5","key":"10.1016\/j.bcp.2026.118028_b0235","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10059-010-0067-2","article-title":"HIF-1 and HIF-2 transcription factors\u2013similar but not identical","volume":"29","author":"Loboda","year":"2010","journal-title":"Mol. Cells"},{"issue":"8","key":"10.1016\/j.bcp.2026.118028_b0240","doi-asserted-by":"crossref","first-page":"e746","DOI":"10.1111\/aos.13096","article-title":"Inhibition of HIF-1alpha decreases expression of pro-inflammatory IL-6 and TNF-alpha in diabetic retinopathy","volume":"95","author":"Gao","year":"2017","journal-title":"Acta Ophthalmol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118028_b0245","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.intimp.2004.11.009","article-title":"Cytokines and the regulation of hypoxia-inducible factor (HIF)-1alpha","volume":"5","author":"Haddad","year":"2005","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118028_b0250","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13062-024-00487-w","article-title":"Hypoxia-induced activation of HIF-1alpha\/IL-1beta axis in microglia promotes glioma progression via NF-kappaB-mediated upregulation of heparanase expression","volume":"19","author":"Si","year":"2024","journal-title":"Biol. Direct"},{"issue":"12","key":"10.1016\/j.bcp.2026.118028_b0255","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1038\/emm.2015.88","article-title":"Crosstalk between FLS and chondrocytes is regulated by HIF-2alpha-mediated cytokines in arthritis","volume":"47","author":"Huh","year":"2015","journal-title":"Exp. Mol. Med."},{"issue":"9","key":"10.1016\/j.bcp.2026.118028_b0260","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200667","article-title":"Hypoxia-inducible factors individually facilitate inflammatory myeloid metabolism and inefficient cardiac repair","volume":"218","author":"DeBerge","year":"2021","journal-title":"J. Exp. Med."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226003618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226003618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:32:59Z","timestamp":1792888379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226003618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":52,"alternative-id":["S0006295226003618"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118028","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Divergent mechanisms, unified therapy: saracatinib targets Src\/HIF signaling in endothelial and microglial cells to treat retinopathy","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118028"}}